New Method to Measure Lung Antibodies from the Lower Airways Could Boost Development of Mucosal Vaccines - Scorecard - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Noninvasive Lower-Airway Antibody Measurement May Advance Mucosal Vaccine Development

  • By

  • Debbie Bunch

  • November 16, 2026

Share

Clinical Scorecard: Noninvasive Lower-Airway Antibody Measurement May Advance Mucosal Vaccine Development

At a Glance

CategoryDetail
ConditionMeasurement of antigen-specific antibodies in lower-airway respiratory tract lining fluid
Key MechanismsParticles in Exhaled Air (PExA) collects aerosolized lining fluid from distal airways for measurement of antigen-specific IgA and IgG.
Target PopulationThe proof-of-concept analysis included 28 health care workers, 18 of whom had confirmed COVID-19, influenza, or RSV.
Care SettingResearch assessment of mucosal immunity and vaccine responses; broader clinical or interventional use requires further study.

Key Highlights

  • PExA measurements of antigen-specific IgA and IgG showed low variability in the study samples.
  • PExA and serum IgG measurements were strongly correlated; correlations for IgA were weaker.
  • Antibody levels correlated between PExA samples and nasal secretions, while nasal secretions had a higher IgA/IgG ratio.
  • The authors describe PExA as a practical approach for studying lower-airway mucosal immunity and evaluating mucosal vaccines.

Guideline-Based Recommendations

Diagnosis

  • The article describes an antibody-measurement method, not diagnostic recommendations for respiratory infections.

Management

  • The authors call for further study of PExA’s broader applicability and potential use in clinical or interventional research, including assessment of next-generation mucosal vaccines.

Monitoring & Follow-up

  • PExA samples can be analyzed for antigen-specific IgA and IgG; the study reports low variability in these measurements.

Risks

  • The article notes that induced sputum predominantly samples larger, more proximal airways and may be susceptible to upper-airway contamination.

Patient & Prescribing Data

Samples were analyzed from 28 health care workers; 18 had confirmed COVID-19, influenza, or RSV.

No treatment or prescribing data are reported. The study evaluates a sampling method relevant to research on mucosal vaccines.

Clinical Best Practices

  • For the described PExA procedure, participants breathe through a mouthpiece connected to the instrument by a two-way non-rebreathing valve, with a nose clip in place.
  • Before testing, participants inhale HEPA-filtered air to eliminate particles originating in ambient air.
  • Interpret antibody correlations as study findings: PExA and serum IgG were strongly correlated, whereas IgA correlations were weaker.

Related Resources & Content

Original Source(s)

Related Content